NRX Pharmaceuticals, Inc. (NRXP) stock
NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.15−0.40 (-15.69%)
Close on Nov 20, 2026Market cap $93.09MP/E –Yield –
NRX Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
NRX Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $3.39M. For fiscal 2025 it was $1.23M.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.10M | – |
| Q1 FY2026 | Mar 31, 2026 | $1.07M | – |
| Q4 FY2025 | Dec 31, 2025 | $983.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $242.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
See a number that looks wrong?